Dramatic response under combination of immune-oncology in head & neck cancer included in the Condor study: A case report

被引：0
|
作者：
Daste, Amaury [1 ]
Digue, Laurence [1 ]
Ravaud, Alain [1 ,2 ]
Domblides, Charlotte [1 ,2 ,3 ]
机构：
[1] Bordeaux Univ, Hosp CHU Bordeaux, Hop St Andre, Dept Med Oncol, Bordeaux, France
[2] Univ Bordeaux, Bordeaux, France
[3] Bordeaux Univ, CNRS, ImmunoConcEpt, UMR 5164, F-33076 Bordeaux, France
来源：
ORAL ONCOLOGY | 2019年 / 89卷
关键词：
SQUAMOUS-CELL CARCINOMA; NIVOLUMAB; RECURRENT;
D O I：
10.1016/j.oraloncology.2019.01.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 152
页数：3
相关论文
共 36 条
  • [1] Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
    Christin Riess
    Nina Irmscher
    Inken Salewski
    Daniel Strüder
    Carl-Friedrich Classen
    Christina Große-Thie
    Christian Junghanss
    Claudia Maletzki
    Cancer and Metastasis Reviews, 2021, 40 : 153 - 171
  • [2] Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma-backbone or add-on in immune-oncology?
    Riess, Christin
    Irmscher, Nina
    Salewski, Inken
    Strueder, Daniel
    Classen, Carl-Friedrich
    Grosse-Thie, Christina
    Junghanss, Christian
    Maletzki, Claudia
    CANCER AND METASTASIS REVIEWS, 2021, 40 (01) : 153 - 171
  • [3] A combination of bortezomib and rituximab yields a dramatic response in a woman with highly refractory immune thrombocytopenic purpura: A case report
    Vinayek N.
    Sharma V.
    Journal of Medical Case Reports, 8 (1)
  • [4] Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer
    Jiang, Siqing
    Li, Xin
    Li, Jin
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] VALIDITY OF LONG-TERM ONCOLOGY MODELING EXTRAPOLATIONS: A CASE STUDY IN RECURRENT OR METASTATIC HEAD AND NECK CANCER
    Borse, Rh
    Hu, Ph
    Ramakrishnan, K.
    Black, C.
    VALUE IN HEALTH, 2022, 25 (01) : S59 - S60
  • [6] Melatonin-Associated Facial Swelling in an Oncology Patient: Case Report and Review of Swelling of the Face in Individuals With Head and Neck Cancer
    Patel, Ravi C.
    Kubicki, Shelby L.
    Cohen, Philip R.
    MacFarlane, Deborah F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [7] Elevated carcinoembryonic antigen tumour marker caused by head and neck cancer: A case report and literature study
    Vingerhoedt, S. I.
    Hauben, E.
    Hermans, R.
    Vander Poorten, V. L.
    Nuyts, S.
    CANCER RADIOTHERAPIE, 2015, 19 (02): : 106 - 110
  • [8] Preclinical case study: Patient-derived head and neck cancer xenograft on mice humanized with autologous immune cells, a model for personalized immuno-oncology research
    Stecklum, Maria
    Klinghammer, Konrad
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Joehrens, Korinna
    Hoffmann, Jens
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [9] PRECLINICAL CASE STUDY: PATIENT-DERIVED HEAD AND NECK CANCER XENOGRAFT ON MICE HUMANIZED WITH AUTOLOGOUS IMMUNE CELLS, A MODEL FOR PERSONALIZED IMMUNO-ONCOLOGY RESEARCH
    Stecklum, M.
    Klinghammer, K.
    Wulf-Goldenberg, A.
    Brzezicha, B.
    Joehrens, K.
    Hoffmann, J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A27 - A28
  • [10] Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
    Canovas, Manuel Sanchez
    Hernandez, Miguel Angel Moya
    Adoamnei, Evdochia
    Lavin, Diego Cacho
    Garay, David Fernandez
    Verduguez, Teresa Quintanar
    Revuelta, Jacobo Rogado
    Verdejo, Francisco Jose Garcia
    Adrian, Silvia Garcia
    Perez, Ana Isabel Ferrer
    Garcia, Maria Esperanza Guirao
    Robles, Javier Lopez
    Mendiola, Jaime
    Martin, Andres J. Munoz
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (01): : 175 - 181
1234